Oneib Khan
YOU?
Author Swipe
View article: Body mass index from the RE-LY trial: further evidence of the obesity paradox
Body mass index from the RE-LY trial: further evidence of the obesity paradox Open
Background The obesity paradox has been reported in 3 post-hoc analyses evaluating the direct oral anticoagulants (DOAC) against warfarin (W): apixaban (ARISTOTLE), rivaroxaban (ROCKET), and edoxaban (ENGAGE-AF). Purpose To evaluate the ob…